CTX130 Trademark

Trademark Overview

On Monday, February 11, 2019, a trademark application was filed for CTX130 with the United States Patent and Trademark Office. The USPTO has given the CTX130 trademark a serial number of 88296767. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 19, 2022. This trademark is owned by CRISPR Therapeutics AG. The CTX130 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
ctx130

General Information

Serial Number88296767
Word MarkCTX130
Filing DateMonday, February 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
Goods and ServicesGene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 2, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCRISPR Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZUG V8 6300
CH
Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Monday, December 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, April 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2022SOU EXTENSION 5 GRANTED
Thursday, April 7, 2022SOU EXTENSION 5 FILED
Thursday, April 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 7, 2022TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 1, 2021SOU EXTENSION 4 GRANTED
Monday, November 1, 2021SOU EXTENSION 4 FILED
Monday, November 1, 2021TEAS EXTENSION RECEIVED
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 3 GRANTED
Wednesday, April 14, 2021SOU EXTENSION 3 FILED
Wednesday, April 14, 2021TEAS EXTENSION RECEIVED
Wednesday, April 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020SOU EXTENSION 2 GRANTED
Wednesday, November 11, 2020SOU EXTENSION 2 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2020SOU EXTENSION 1 GRANTED
Monday, May 11, 2020SOU EXTENSION 1 FILED
Monday, May 11, 2020TEAS EXTENSION RECEIVED
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2019ASSIGNED TO LIE
Tuesday, August 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2019NON-FINAL ACTION WRITTEN
Friday, April 19, 2019ASSIGNED TO EXAMINER
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

gene treatment namely research editing pharmaceutical cancer medical development pharmaceuticals